Company news
Heramed Ltd (ASX:HMD) news
Heramed Ltd news releases on 6ix. Latest, Feb 28, 2023: Appendix 4E & Preliminary Final Report
Press releases — page 2
Appendix 4E & Preliminary Final Report
February 28, 2023
Successful First Phase - e-Lovu Initial Commercial Rollout
February 19, 2023
Ramsay Affiliated Melbourne Mothers Practice Adopts HeraCARE
November 22, 2022
HeraMED Completes $4 Million Private Placement
August 24, 2022
HMD & e-Lovu Health Partnership for HeraCARE Deployment US
July 27, 2022
Sheba HeraBEAT Clinical Trial Completed - Excellent Results
July 18, 2022
JHC agrees to full commercial rollout of HeraCARE
January 20, 2022
Reinstatement to Official Quotation
January 20, 2022
Response to ASX Price Query
November 15, 2021
$2.39 million raised via a Convertible Note
October 17, 2021
Positive Interim Results US Paid Pilot & 2nd Site Confirmed
September 13, 2021
HeraCARE Shortlisted for Government tender in Spain
September 1, 2021
HeraCARE paid pilot commences at Joondalup Health Campus
August 12, 2021
Pilot agreement signed with US leader Obstetrix Medical
May 13, 2021
HeraCARE commercial agreement with Joondalup Health Campus
April 21, 2021
Israels Largest Healthcare Provider Begins Pilot Study
February 7, 2021
Completion of AUD 2.3M Placement
February 3, 2021
Mayo Clinic approves Clinical Study of HeraBEAT
December 15, 2020
Partnership to Launch HeraCARE & HeraBEAT with Teleperinatal
December 14, 2020
Partnership with eCare21 & functional integration completed
November 8, 2020
Clinical & Functional Validation of HeraBEAT Achieved at JHC
October 7, 2020
Partnership with Leading Virtual Care Platform eCare21 in US
September 15, 2020
Updated Quarterly Activities Report
August 3, 2020
HeraMED Extends its Collaboration with Mayo Clinic
July 20, 2020
Pause In Trading
July 16, 2020
Results of Share Purchase Plan Offer
July 13, 2020
Final Approvals Received to Commence Clinical Study
July 12, 2020
Company Presentation - June 2020
June 5, 2020
HMD Raises $2.32 Million and Launches SPP
June 4, 2020
Agreement with Freeman Rd & PHI Group - Pilots in Australia
May 19, 2020
Exclusive Agreement Executed with Australian Distributor
May 7, 2020
Quarterly Activities and CashFlow Report
April 30, 2020
US Market Entry Strategy Update
April 6, 2020
HMD Update & COVID-19 Opportunities Conference Call
March 24, 2020
Company Update - COVID-19 To Accelerate Global Opportunities
March 23, 2020
HeraCARE Product Development Update
March 1, 2020
HeraMED appoints US General Manager of Operations
February 2, 2020
December Quarter Activities Report and Appendix 4C
January 29, 2020
HMD accesses unique pregnancy database to strengthen OrionAI
January 20, 2020
Response to ASX Aware Query
January 19, 2020
A$1.42m strategic placement completed to expedite US entry
December 9, 2019
Indian Hospital Group Cooperates with H-Cube and HeraMED
November 24, 2019
Agreement adds telehealth services to Herabeat in Germany
November 20, 2019
HeraMED Receives FDA 510(k) Clearance for HeraBEAT Device
November 17, 2019
Retraction of Statements - Next Tech Stock Article
November 15, 2019
Pause in Trade
November 14, 2019
Response to ASX Price and Volume Query
November 13, 2019
September Quarter Activities Report and Appendix 4C
October 29, 2019
Market entry for HeraBEAT and HeraCARE Progresses in India
October 24, 2019
HeraMED Solutions Operational Across Multiple Hapvida Sites
August 27, 2019